pixelentropy

CPE raises awareness of ESR1 mutations in metastatic breast cancer, promoting liquid biopsy and personalized care through EU-led advocacy and research. Read More

Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare blood cancer originating from precursor dendritic cells. This form of rare cancer has often gone underdiagnosed due to misclassification and lack of knowledge. To address this, CPE aims to increase awareness amongst society to promote positive outcomes. Read More

QUALITOP is an EU-funded project that aims to improve the well-being and quality of life of cancer patients undergoing immunotherapy. Cancer Patients Europe plays a vital role by leading communication and dissemination efforts, ensuring the project’s findings reach patients, healthcare professionals, and policymakers. Read More

CPE is a consortium member of the EU-funded-project: GLIOMATCH which seeks to revolutionise treatment outcomes for Paediatric High-grade Glioma (pHGG) and Glioblastoma Multiforme (GBM) patients through advanced immunology-based stratification and therapy matching. Read More